Free Cash Flow: A measure of financial performance calculated as operating cash flow minus capital expenditures. Calculated as: Cash Flow from Operations + Net Property, Plant & Equipment Exp (a negative number)
Greenwich LifeSciences, Inc. (GLSI) had Free Cash Flow of $-1.83M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-3.26M |
|
-- |
|
-- |
|
$3.28M |
|
$-3.28M |
|
$0.02M |
|
$-3.26M |
|
$-3.26M |
|
$-3.26M |
|
$-3.26M |
|
$-3.26M |
|
$-3.26M |
|
$-3.28M |
|
$-3.28M |
|
13.17M |
|
13.17M |
|
$-0.25 |
|
$-0.25 |
|
| Balance Sheet Financials | |
$2.75M |
|
-- |
|
$0.00M |
|
$2.75M |
|
$1.44M |
|
-- |
|
-- |
|
$1.44M |
|
$1.31M |
|
$1.31M |
|
$1.31M |
|
13.19M |
|
| Cash Flow Statement Financials | |
$-1.83M |
|
-- |
|
$0.49M |
|
$4.09M |
|
$2.75M |
|
$-1.34M |
|
$1.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.91 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Free Cash Flow |
$-1.83M |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-248.29% |
|
-248.46% |
|
-118.45% |
|
-248.29% |
|
$0.10 |
|
$-0.14 |
|
$-0.14 |
|